VLDLR Polyclonal Antibody, 100ul NGS Oligos through a mechanism that involves

through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation

The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins

500mL*2pcs

and cell differentiation

It is localized in nuclear bodies of the nucleus

VLDLR Polyclonal Antibody, 100ul NGS Oligos through a mechanism that involvesThe low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants